In patients with decreased hepatic steatosis, we found lower baseline levels of profibrotic, proinflammatory, and pro-apoptotic platelet-derived TGF-1, HMGB1, and pCXCR4. The gene discussed is HMGB1; the disease is Hepatic steatosis.